- Home
- INCR vs FORA Comparison
INCR vs FORA Comparison
Compare INCR & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- FORA
- Stock Information
- Founded
- INCR 1994
- FORA 2014
- Country
- INCR Israel
- FORA United States
- Employees
- INCR N/A
- FORA N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- INCR Health Care
- FORA Technology
- Exchange
- INCR Nasdaq
- FORA Nasdaq
- Market Cap
- INCR 76.7M
- FORA 77.6M
- IPO Year
- INCR N/A
- FORA N/A
- Fundamental
- Price
- INCR $1.64
- FORA $2.41
- Analyst Decision
- INCR
- FORA Strong Buy
- Analyst Count
- INCR 0
- FORA 1
- Target Price
- INCR N/A
- FORA $5.00
- AVG Volume (30 Days)
- INCR 27.5K
- FORA 55.9K
- Earning Date
- INCR 03-04-2025
- FORA 03-27-2025
- Dividend Yield
- INCR N/A
- FORA N/A
- EPS Growth
- INCR N/A
- FORA N/A
- EPS
- INCR N/A
- FORA N/A
- Revenue
- INCR $72,420,918.00
- FORA $19,709,723.00
- Revenue This Year
- INCR N/A
- FORA N/A
- Revenue Next Year
- INCR $39.30
- FORA $13.59
- P/E Ratio
- INCR N/A
- FORA N/A
- Revenue Growth
- INCR N/A
- FORA N/A
- 52 Week Low
- INCR $1.17
- FORA $1.96
- 52 Week High
- INCR $3.72
- FORA $4.15
- Technical
- Relative Strength Index (RSI)
- INCR 48.90
- FORA 48.34
- Support Level
- INCR $1.61
- FORA $2.35
- Resistance Level
- INCR $1.73
- FORA $4.03
- Average True Range (ATR)
- INCR 0.06
- FORA 0.45
- MACD
- INCR -0.01
- FORA -0.01
- Stochastic Oscillator
- INCR 35.48
- FORA 19.00
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.